Prelude Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$249K Buy
2024
Q3
Sell
2024
Q2
$928K Buy
2020
Q1
Sell
2019
Q4
$6K Sell
2019
Q3
$7K Sell
2019
Q2
$9K Buy
2019
Q1
$12K Sell
2018
Q4
$13K Sell
2018
Q3
$945K Buy
2018
Q2
$326K Buy